NCT05786105View on ClinicalTrials.gov

Optical Genome Mapping in Characterization of Multiple Myeloma

CompletedOBSERVATIONAL
Enrollment

8

Participants

Timeline

Start Date

April 21, 2023

Primary Completion Date

November 21, 2023

Study Completion Date

November 21, 2023

Conditions
Multiple Myeloma
Interventions
OTHER

Bone Marrow samples collection

Bone Marrow samples collection - one ethylenediaminetetraacetic acid (EDTA) tube - for Optical Genome Mapping

Trial Locations (1)

67033

Institut de cancérologie Strasbourg Europe, Strasbourg

All Listed Sponsors
collaborator

GENTYANE (GEnoTYpage and sequencing in AuvergNE)

UNKNOWN

collaborator

Hôpitaux Universitaires de Strasbourg

UNKNOWN

lead

Institut de cancérologie Strasbourg Europe

OTHER